We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Gene drives
- Engineered gene drives
- What species could gene drive technology be applied to?
- Engineered CRISPR/Cas9 gene drives for malaria control
- Quick note
- The structure of gene drive constructs for population modification
- Classic modification gene drive: malaria control (1)
- Classic modification gene drive: malaria control (2)
- Testing a classic gene drive
- Integral gene drives for population modification
- Separating gene drive & antimalarial effector modules
- An integral gene drive (1)
- Ribosome skipping using 2A peptides
- An integral gene drive (2)
- Testing integral gene drives
- Example: the MM-CP integral gene drive effector
- When should antimalarial effectors act?
- Antimicrobial peptides as promising effectors
- Expression of Magainin2 & Melittin from a mosquito midgut gene (1)
- Expression of Magainin2 & Melittin from a mosquito midgut gene (2)
- Oocyst growth severely impaired in homozygous MM-CP females
- Sporozoite development retarded
- Reduced lifespan & reproductive output in homozygous MM-CP females
- Ross-MacDonald equation
- MM-CP allele capable of efficient non-autonomous gene drive
- Modelling the impact of deployment on malaria transmission
- Modelling the impact of MM-CP propagation on malaria transmission
- Testing non-autonomous effectors against patient derived parasites
- Acknowledgements
Topics Covered
- Engineered gene drives
- CRISPR/Cas9
- Gene drive construct structure
- Integral gene drive
- MM-CP integral gene drive effector
- Antimalarial effectors
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Windbichler, N. (2025, May 29). Integral gene drives for malaria control [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved June 1, 2025, from https://doi.org/10.69645/BIMZ7525.Export Citation (RIS)
Publication History
- Published on May 29, 2025
Financial Disclosures
- There are no financial/commercial matters to disclose.
Other Talks in the Series: Gene-Drives and Active Genetics
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Nikolai Windbichler.
I'm a researcher at
Imperial College London,
and I work on malaria control.
This talk is about
Integral Gene Drives
for Malaria Control.
0:13
If you have followed
this series,
then you're probably
familiar with this slide.
Gene drives are traits that
are preferentially inherited.
You can see on the left side,
normal Mendelian inheritance.
You can see that
this trait is inherited
50% of the time,
and therefore,
it doesn't increase in
frequency in the population.
On the right side, we
have a gene drive trait.
This has a high chance
of being inherited,
in the best case, 100%.
As you can see, this trait is
increasingly getting more and
more frequent in the population.
Now, there are many naturally
occurring gene drives,
but this presentation is
about engineered gene drives.
0:55
Engineered gene drives
could be used to
modify wild populations.
If we can build a
gene drive trait,
there are certain things that
we can do with it,
and this is shown on this slide.
It is a strategy called
population suppression.
In this case, we release an engineered
gene drive into a population.
It spreads and at the same time,
it does something that
reduces the fitness of
the target organism
in this population.
The outcome would be that
the population size
will be reduced.
If this organism is
a disease-transmitting
vector, for example,
that would also reduce
disease transmission.
We have another strategy which
is called population
modification or
sometimes referred to as
population replacement.
In this case,
the gene drive spreads
through the population but
it doesn't reduce
the population size.
Instead, it carries along
another trait that,
for example, if they
are malaria vectors,
makes these insects less good
at transmitting the disease.
You will see the two
strategies mentioned in
almost every gene
drive publication.